About Us

Riverain Technologies and Aidoc Join Forces to Bring Time Saving Chest AI solutions

Artificial Intelligence (AI) , Machine Learning (ML), Natural Language Processing (NLP), Deep Learning (DL), AI Model, AI-powered Solutions, Digital Transformation, ML Model, Natural Language Understanding (NLU), AI News, Artificial Intelligence News
A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

In a new collaboration, Aidoc and Riverain Technologies, two of the industry’s leading artificial intelligence (AI) providers, will provide increased AI capabilities for medical imaging. The new partnership will integrate Riverain’s commercially available algorithms with Aidoc’s platform to improve provider access to both solutions. A comprehensive AI solution will now be available to thoracic physicians, medical facilities, and radiology groups, through one platform.

Tom Valent, VP Business Development at Aidoc, said, “Aidoc has mastered various critical findings throughout the body, providing hospitals with a robust AI platform that serves key clinical use cases. With Riverain, we are doubling down on delivering an integrated chest AI package to customers – offering Riverain’s FDA-cleared lung nodule detection and measurement with our FDA-cleared PE, incidental PE, and rib fracture modules. We are excited about the new addition to our growing platform as it will further enable us to offer one point of access to a crucial assembly of clinically proven AI solutions, all delivered in a streamlined manner into existing physician workflows.”

As a result of Aidoc’s solutions, physicians in nearly 600 medical centers around the world can now experience a seamless and unified cross-specialty AI experience. Aidoc’s solutions allow radiologists to identify acute anomalies in real-time, including pulmonary embolism, intracranial bleeding, and strokes, expediting patient treatment and improving quality of care. For the early and efficient detection of lung disease, Riverain developed the first simultaneous read FDA-cleared algorithm. Riverain’s clinically proven and trusted solutions, ClearRead™ CT and ClearRead Xray, function by removing noise from vessels and bones, increasing efficiency in all chest studies, and detecting more nodules.

Mark Koeniguer, Chief Commercial Officer at Riverain Technologies, said, “At Riverain, we deliver technology that transforms futures – our customers trust and value our robust chest health solutions focused on early disease and nodule detection. We are thrilled to collaborate with Aidoc to simplify physician workflow and efficiency while improving lung imaging and care on behalf of patients and providers.”

Recent News